Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis
The Kaohsiung Journal of Medical Sciences · 2025
DOI: 10.1002/kjm2.70106 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Xin Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. Hauptthemen laut MEDLINE: Oxidative Stress, Atherosclerosis, Rosuvastatin Calcium, Plaque, Atherosclerotic. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rosuvastatin (RVS) is an HMG‐CoA reductase inhibitor with lipid‐lowering properties. This study aims to investigate the role of RVS in plaque formation in atherosclerosis (AS) and its functional mechanism. ApoE −/− mice were fed a high‐fat diet to generate a mouse model of AS. RVS treatment reduced serum levels of total cholesterol, triglycerides, and low‐density lipoprotein cholesterol in atherosclerotic mice, alleviated oxidative stress, and ameliorated lipid deposition, plaque formation, and fibrosis in the mouse aortic tissues. In vitro, it reduced reactive oxygen species and suppressed the proliferation and migration of oxidized low‐density lipoprotein‐challenged human vascular smooth muscle cells (HVSMCs). REST corepressor 1 (RCOR1) was identified as a target protein upregulated by RVS. It was found to repress transcription of decidual protein induced by progesterone 1 (DEPP1/C10ORF10) by binding to its promoter. Silencing of RCOR1 negated the AS‐ameliorating effects of RVS in mice and HVSMCs. However, the AS‐like symptoms in mice and HVSMC activity were suppressed by the additional C10ORF10 silencing. In conclusion, this study demonstrates that RVS alleviates oxidative stress and reduces atherosclerotic plaque formation by increasing RCOR1‐mediated transcriptional repression of C10ORF10.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
- Department of Comprehensiveness, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
ORCID-Profile: Xin Fu
Zitieren
APA
Fu, X., Liu, C., Chen, Y. L., Qin, J. L., Wang, T. T., & Fu, S. S. (2025). Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70106
Vancouver
Fu X, Liu C, Chen YL, Qin JL, Wang TT, Fu SS. Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70106
BibTeX
@article{Fu2025,
author = {Fu, Xin and Liu, Chuang and Chen, Ya-Li and Qin, Jie-Lin and Wang, Ting-Ting and Fu, Shan-Shan},
title = {Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2025},
doi = {10.1002/kjm2.70106}
}
EUVIMED